Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPRC | P08575 | 3/20 | 0.53 |
| ▸ | S100A4 | P26447 | 2/20 | 0.53 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | CA12 | O43570 | 2/20 | 0.50 |
| ▸ | CA9 | Q16790 | 2/20 | 0.50 |
| ▸ | CASP1 | P29466 | 1/20 | 0.50 |
| ▸ | CASP3 | P42574 | 1/20 | 0.50 |
| ▸ | CASP4 | P49662 | 1/20 | 0.50 |
| ▸ | CASP7 | P55210 | 1/20 | 0.50 |
| ▸ | CASP9 | P55211 | 1/20 | 0.50 |
| ▸ | CASP6 | P55212 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | TNF | P01375 | 1/20 | 0.48 |
| ▸ | RPS6KA2 | Q15349 | 1/20 | 0.48 |
| ▸ | ACHE | P22303 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31538157 | 0.81 | CA12 (0.52) | PTPRCS100A4ALOX5ALDH1A1CA12 | |
| SCHEMBL29945629 | 0.81 | CASP1 (0.63) | PTPRCS100A4ALOX5ALDH1A1CA12 | |
| SCHEMBL516995 | 0.81 | CASP1 (0.63) | PTPRCS100A4ALOX5ALDH1A1CA12 | |
| SCHEMBL18017059 | 0.81 | PTPRC (0.50) | PTPRCS100A4ALOX5ALDH1A1CA12 | |
| SCHEMBL28549286 | 0.80 | ALOX5 (0.55) | PTPRCS100A4ALOX5ALDH1A1CA12 | |
| SCHEMBL13495342 | 0.79 | CASP1 (0.43) | PTPRCS100A4ALDH1A1CASP1CASP3 | |
| SCHEMBL16702921 | 0.77 | PTPRC (0.58) | PTPRCS100A4ALOX5ALDH1A1CA12 | |
| SCHEMBL1704508 | 0.77 | PTPRC (0.58) | PTPRCS100A4ALOX5ALDH1A1CA12 | |
| SCHEMBL3202418 | 0.77 | PTPRC (0.58) | PTPRCS100A4ALOX5ALDH1A1CA12 | |
| SCHEMBL30781599 | 0.77 | PTPRC (0.58) | PTPRCS100A4ALOX5ALDH1A1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114213637-A | Synthetic method of high-molecular-weight polylactic acid | 江苏睿安应用生物技术股份有限公司 | 2022-03-22 | — | — | CN | claimed |
| CN-114213637-A | Synthetic method of high-molecular-weight polylactic acid | 江苏睿安应用生物技术股份有限公司 | 2022-03-22 | — | — | CN | disclosed |
| US-8329377-B2 | Imide compound and chemically amplified resist composition containing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-12-11 | — | — | US | disclosed |
| US-8329377-B2 | Imide compound and chemically amplified resist composition containing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-12-11 | — | — | US | disclosed |
| US-20100028807-A1 | Imide Compound and Chemically Amplified Resist Composition Containing The Same | SUMITOMO CHEMICAL COMPANY, LTD. (JP) | 2010-02-04 | — | — | US | disclosed |
| US-20100028807-A1 | Imide Compound and Chemically Amplified Resist Composition Containing The Same | SUMITOMO CHEMICAL COMPANY, LTD. (JP) | 2010-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100028807-A1 | Imide Compound and Chemically Amplified Resist Composition Containing The Same | IGF1R, CCNA1, MYC | PTPRC 2632/4885S100A4 1788/4885ALOX5 2840/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.